Copyright
©The Author(s) 2016.
World J Cardiol. Oct 26, 2016; 8(10): 596-605
Published online Oct 26, 2016. doi: 10.4330/wjc.v8.i10.596
Published online Oct 26, 2016. doi: 10.4330/wjc.v8.i10.596
Table 1 Reviewed Asian (n = 111) and Caucasian (n = 100) group of patients
Total reviewed subjects | Asian group | Caucasian group | |
n | 211 | 111 (53%) | 100 (47%) |
Gender | F 124 (59%) | F 63 (57%) | F 61 (61%) |
M 87 (41%) | M 48 (43%) | M 39 (39%) | |
Mean age (range)1, yr | 49.4 (16-85) | 48.9 (19-83) | 49.9 (16-85) |
CAF characteristics | |||
Unilateral | 118 (56%) | 42 (38%) | 76 (76%) |
Bilateral | 87 (41%) | 63 (57%) | 24 (24%) |
Multilateral | 6 (3%) | 6 (5%) | - |
Mode of termination | |||
CVFs | 90 (43%) | 43 (39%) | 47 (47%) |
CCFs | 121 (57%) | 68 (61%) | 53 (53%) |
RHC | 201 (95%) | 107 (96%) | 94 (94%) |
sPAP/RVSP | 10 (5%) | 4 (4%) | 6 (6%) |
Management | |||
CMM | 38 | 20 | 18 |
PTE2 | 29 | 9 (8%) | 20 (20%) |
SL | 124 (59%) | 82 (74%) | 42 (42%) |
WW | 2 | - | 2 |
Death | 2 | - | 2 |
Not mentioned | 16 | - | 16 |
Table 2 Asian and Caucasian group of patients (n = 49) with pulmonary hypertension
Total group | Asian group | Caucasian group | |
n | 49 | 15 (31%) | 34 (69%) |
Age1 | 56 (16-80) | 54.4 (24-77) | 56.8 (16-80) |
Gender | F 34 (69%) | F 12 (80%) | F 22 (65%) |
M 15 (31%) | M 3 (20%) | M 12(35%) | |
CAF | |||
Unilateral | 37 (76%) | 9 (60%) | 28 (82%) |
Bilateral | 12 (24%) | 6 (40%) | 6 (18%) |
PHT | |||
Mild | 26 (53%) | 8/15 (53%) | 18/34 (53%) |
Moderate | 11 (22%) | 2/15 (13%) | 9/34 (26%) |
Severe | 12 (25%) | 5/15 (33%) | 7/34 (21%) |
Mean PAP (mmHg) | 35.6 (range 26-60) | 36.9 (range 27-49) | 34.3 (range 26-60) |
Mean Qp:Qs ratio | 1.9 (range 1.13-2.75) | 1.9 (range 1.13-2.75) | 1.9 (range 1.3-2.7) |
RHC | 43 (88%) | 13 (87%) | 30 (88%) |
Doppler (sPAP) | 6 (12%) | 2 (13%) | 4 (12%) |
CAF characteristics | |||
Origin | R 8, L 30, bilateral 11 | R 2, L 8, bilateral 5 | R 6, L 22, bilateral 6 |
Termination | RH side 45 LH side 4 | RH side 13 LH side 2 | RH side 32 LH side 2 |
Mode of termination | |||
CVFs | 37 (76%) | 9/15 (60%) | 28/34 (82%) |
CCFs | 12 (24%) | 6/15 (40%) | 6/34 (18%) |
Associated disorders | 17/49 (35%) | 5/15 (33%) | 12/34 (35%) |
Management | |||
SL | 30 (61%) | 9 | 21 |
PTE | 13 (27%) | 4 | 92 |
CMM | 6 (12%) | 2 | 4 |
Table 3 Mode of termination coronary-vascular fistulas vs coronary-cameral fistulas in the pulmonary hypertension (n = 49) and all reviewed (n = 211) subjects
CVFs | CCFs | Mean age and range (yr) | |
Total n = 211 | 90/211 (43%) | 121/211(57%) | 38.3 (26-67) |
Asian 15/111 (14%) | 9/15 (60%) | 6/15 (40%) | 39.7 (27-67) |
Caucasian 34/100 (34%) | 28/34 (82%) | 6/34 (18%) | 36.8 (26-60) |
Table 4 Possible complications of coronary artery fistulas
Complication | Features |
Cardiovascular | Myocardial infarction, stroke, aneurysm, rupture |
Infectious | Bacterial endocarditis, septic pulmonary and septic renal embolism |
Valvular | Incompetence, dysfunction, perforation |
Pericardial | Hemopericardium, pericardial effusion, tamponade |
Myocardial | Congestive heart failure |
Arrhythmic | Supraventricular arrhythmias, ventricular arrhythmias and sudden death |
- Citation: Said SA. Congenital coronary artery fistulas complicated with pulmonary hypertension: Analysis of 211 cases. World J Cardiol 2016; 8(10): 596-605
- URL: https://www.wjgnet.com/1949-8462/full/v8/i10/596.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i10.596